Resultados: 14

2017 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary

Olasveengen, TM; de, Caen, AR; Mancini, ME; Maconochie, IK; Aickin, R; Atkins, DL; Berg, RA; Bingham, RM; Brooks, SC; Castrén, M; Chung, SP; Considine, J; Couto, TB; Escalante, R; Gazmuri, RJ; Guerguerian, AM; Hatanaka, T; Koster, RW; Kudenchuk, PJ; Lang, E; Lim, SH; Løfgren, B; Meaney, PA; Montgomery, WH; Morley, PT; Morrison, LJ; Nation, KJ; Ng, KC; Nadkarni, VM; Nishiyama, C; Nuthall, G; Ong, GY; Perkins, GD; Reis, AG; Ristagno, G; Sakamoto, T; Sayre, MR; Schexnayder, SM; Sierra, AF; Singletary, EM; Shimizu, N; Smyth, MA; Tijssen, JA; Travers, A; Vaillancourt, C; Van, de, Voorde, P; Hazinski, MF; Nolan, JP.

Circulation; 136 (23), 2017

The International Liaison Committee on Resuscitation has initiated a near-continuous review of cardiopulmonary resuscitation science that replaces the previous 5-year cyclic batch-and-queue approach process. This is the first of an annual series of International Consensus on Cardiopulmonary Resuscitation...

Fatores Etários, Cardiologia/normas, Reanimação Cardiopulmonar/normas, Serviços Médicos de Emergência/normas, Medicina de Emergência/normas, Parada Cardíaca, Parada Cardíaca Extra-Hospitalar, Resultado do Tratamento, Parada Cardíaca/diagnóstico, Parada Cardíaca/mortalidade, Parada Cardíaca/terapia, Reanimação Cardiopulmonar, Parada Cardíaca Extra-Hospitalar/diagnóstico, Parada Cardíaca Extra-Hospitalar/mortalidade, Parada Cardíaca Extra-Hospitalar/terapia

Texto completo

European Respiratory Society guidelines for the management of adult bronchiectasis

Polverino, E; Goeminne, P. C; McDonnell, M. J; Aliberti, S; Marshall, S. E; Loebinger, M. R; Murris, M; Cantón, R; Torres, A; Dimakou, K; Soyza, A. de; Hill, A. T; Haworth, C. S; Vendrell, M; Ringshausen, F. C; Subotic, D; Wilson, R; Vilaró, J; Stallberg, B; Welte, T; Rohde, G; Blasi, F; Elborn, S; Almagro, M; Timothy, A; Ruddy, T; Tonia, T; Rigau, D; Chalmers, J. D.

Eur. respir. j; 50 (3), 2017

Bronchiectasis in adults is a chronic disorder associated with poor quality of life and frequent exacerbations in many patients. There have been no previous international guidelines.The European Respiratory Society guidelines for the management of adult bronchiectasis describe the appropriate investigati...

Bronquiectasia/tratamento farmacológico, Antibacterianos/uso terapêutico, Anti-Inflamatórios/uso terapêutico, Broncodilatadores/uso terapêutico, Modalidades de Fisioterapia, Bronquiectasia/cirurgia

Texto completo

Cost variation of antipsychotics in the public health system in Brazil: the implication for health resource use

Razzouk, Denise.

J. bras. econ. saúde (Impr.); 9 (Suplemento 1), 2017

Objective: This study aimed to verify the variation on antipsychotics costs according to four unit costs paid by public health providers in Brazil. Methods: This cross-sectional study used the health provider perspective and bottom-up approach to evaluate 134 subjects with mental disorders, in regular us...

Antipsicóticos, Custos e Análise de Custo, Serviços Comunitários de Saúde Mental, Política de Saúde, Transtornos Mentais, Alocação de Recursos

Texto completo (link principal)     Texto completo (link alternativo)    

The economic impact of providing dengue vaccination in the workplace in Brazil

Durand, Laure; Grailles, Louise; Boissière, Christophe; Beucher, Sophie.

J. bras. econ. saúde (Impr.); 9 (Suplemento 1), 2017

Objective: To estimate the economic value of implementing a workplace dengue vaccination program from an employer perspective. Methods: The cost of a vaccination program was compared with the economic benefits in terms of reduced absenteeism and presenteeism in companies in Brazil. Input data were obtain...

Vacinação, Dengue, 16359, Análise Custo-Benefício

Texto completo (link principal)     Texto completo (link alternativo)    

Análise de custo-efetividade da toxina onabotulínica A no tratamento preventivo da migrânea crônica sob a perspectiva do sistema privado de saúde do Brasil

Piovesan, Elcio; Cadecaro, Patricia; Pepe, Camila.

J. bras. econ. saúde (Impr.); 9 (Suplemento 1), 2017

Objetivo: Avaliar o custo-efetividade da toxina onabotulínica A (TB) versus ausência de tratamento “não tratar” (NT) da migrânea crônica refratária a pelo menos dois medicamentos em um Sistema de Saúde Suplementar. Métodos: Modelo analítico de decisão simulou desfechos e custos em 24 semana...

Análise Custo-Benefício, Cefaleia, Toxinas Botulínicas Tipo A, Saúde Suplementar

Texto completo (link principal)     Texto completo (link alternativo)    

Custo-efetividade de terapias anti-PD-1 comparadas com ipilimumabe para o tratamento de melanoma avançado sob a perspectiva do sistema de saúde suplementar brasileiro

Tanaka, Straus; Aratangy, Guilherme; Carelli, Guareide; Fahham, Lucas; Pepe, Camila; Bernardino, Graziela.

J. bras. econ. saúde (Impr.); 9 (Suplemento 1), 2017

Objetivo: Realizar uma análise de custo-efetividade das terapias imuno-oncológicas anti-PD-1 aprovadas no Brasil versus ipilimumabe no tratamento do paciente sem tratamento prévio com melanoma metastático (estádios III ou IV), independentemente da mutação BRAF sob a perspectiva do sistema de saúd...

Análise Custo-Benefício, Melanoma, Saúde Suplementar

Texto completo (link principal)     Texto completo (link alternativo)    

Economic evaluation of antipsychotics for the treatment of schizophrenia: a systematic review

Santos, André Soares; Godói, Isabella Piassi; Vidal, Carlos Eduardo Leal; Ruas, Cristina Mariano.

J. bras. econ. saúde (Impr.); 9 (2), 2017

Objective: The aim of this study is to conduct a systematic review on cost-effectiveness analysis of oral antipsychotic agents to identify the trend of cost-effectiveness of drugs available for the treatment of schizophrenia. Methods: A search was conducted in three databases (MEDLINE, LILACS and PsycINF...

Esquizofrenia, Antipsicóticos, Análise Custo-Benefício, Revisão

Texto completo (link principal)     Texto completo (link alternativo)    

Systematic review of nonpharmacological analgesic interventions for common needle‐related procedure in newborn infants and development of evidence‐based clinical guidelines

Lago, P; Garetti, E; Bellieni, CV; Merazzi, D; Savant Levet, P; Ancora, G; Pirelli, A.

Acta paediatr; 106 (6), 2017

The aim of this literature review was to develop clinical guidelines for the prevention and control of needle-related pain in newborn infants. The guidelines were developed by the Italian Society of Neonatology, using the Grading of Recommendations, Assessment, Development and Evaluation approach, based ...

Analgesia, Flebotomia

Texto completo

Cost-effectiveness of dengue vaccination in Brazil

Durand, Laure; Genovez, Victoria; Araujo, Denizar Vianna.

J. bras. econ. saúde (Impr.); 9 (1), 2017

Objective: To define the economic value of a tetravalent dengue vaccine in Brazil by estimating the cost-effectiveness vaccine price threshold per dose. Methods: A dengue dynamic transmission model was used to estimate the public health impact of dengue vaccination and related economic parameters. Two va...

Análise Custo-Benefício, Vacinação, Dengue

Texto completo (link principal)     Texto completo (link alternativo)    

Cost-minimization and budget impact analysis of certolizumab pegol for patients with Crohn’s disease, moderate or severe, with relapse after conventional treatment from the perspective of the Brazilian private payer

Rosim, Ricardo Papaléo; Duva, Andreas de Souza; Ferraz, André Fabre Ballalai; Valle, Arcangela; Tóth, Emese; Ferguson, Samara; Carmo, Érico V. S.

J. bras. econ. saúde (Impr.); 9 (1), 2017

Objectives: Budget impact and cost-effectiveness analysis are often required by payers when discussing drug reimbursement. We hereby present a cost-minimization (CMA) and budget impact analysis (BIA) regarding the incorporation of certolizumab pegol (CZP) for the treatment of patients with Crohn’s dise...

Doença de Crohn, Avaliação da Tecnologia Biomédica, Produtos Biológicos

Texto completo (link principal)     Texto completo (link alternativo)